Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine HCl in Exercise-induced Arterial Hypoxemia in Swimmers
NCT05095311Phase 4Terminated
- Sponsor
- Indiana University
- Start
- May 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetirizine in arterial hypoxemia, sponsored by Indiana University. Started May 2021; status: terminated.
02
Drugs
cetirizine
03
Conditions
arterial hypoxemia
Beyond the preview
Go deeper on NCT05095311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095311.